Literature DB >> 1536652

Differentiation of binding sites on reconstituted hepatic scavenger receptors using oxidized low-density lipoprotein.

E Ottnad1, D P Via, J Frübis, H Sinn, E Friedrich, R Ziegler, H A Dresel.   

Abstract

Reduced hepatic membrane receptors for acetylated low-density lipoprotein (acetyl-LDL) and maleylated BSA (Mal-BSA) with apparent molecular masses of 35 kDa, 85 kDa and 15 kDa have been extracted from rat liver and separated by affinity chromatography as described by us previously [Ottnad, Via, Sinn, Freidrich, Ziegler & Dresel (1990) Biochem. J. 265, 689-698]. Binding of these three reduced scavenger receptors to oxidatively modified LDL has been now examined. Competition studies with receptor-phosphatidylcholine complexes and 131I-acetyl-LDL and 131I-Mal-BSA as ligands were conducted. Mal-BSA, acetyl-LDL and fully oxidized LDL were used as competitors, and differentiated in the three receptors three types of binding site: a class I binding site for acetyl-LDL, Mal-BSA and fully oxidized LDL; a class II binding site recognizing only 131I-Mal-BSA and class III binding sites recognizing 131I-Mal-BSA and fully oxidized LDL. The results of competition studies with mildly oxidized LDL and polyadenylic acid demonstrated that the binding sites might be even more heterogenous. Thus there is evidence that the reconstituted receptors either have several binding sites for each of the various ligands or are functionally different, despite the fact that they do not differ in their apparent molecular masses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536652      PMCID: PMC1130754          DOI: 10.1042/bj2810745

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Low density lipoprotein undergoes oxidative modification in vivo.

Authors:  W Palinski; M E Rosenfeld; S Ylä-Herttuala; G C Gurtner; S S Socher; S W Butler; S Parthasarathy; T E Carew; D Steinberg; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins.

Authors:  H Arai; T Kita; M Yokode; S Narumiya; C Kawai
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Partial purification and characterization of the low density lipoprotein receptor from bovine adrenal cortex.

Authors:  W J Schneider; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1980-12-10       Impact factor: 5.157

7.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages.

Authors:  M S Brown; S K Basu; J R Falck; Y K Ho; J L Goldstein
Journal:  J Supramol Struct       Date:  1980

8.  Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor.

Authors:  D P Via; H A Dresel; S L Cheng; A M Gotto
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

9.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Authors:  S Ylä-Herttuala; W Palinski; M E Rosenfeld; S Parthasarathy; T E Carew; S Butler; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: one or two receptors?

Authors:  H A Dresel; E Friedrich; D P Via; H Sinn; R Ziegler; G Schettler
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  9 in total

Review 1.  Oxidative stress in cardiovascular disease.

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; N Santanam
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

Review 2.  Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family.

Authors:  Gerald J Mizejewski
Journal:  Tumour Biol       Date:  2010-12-01

3.  Uptake of fractionated 3H-heparin by isolated rat Kupffer cells.

Authors:  J Watanabe; M Haba; H Yuasa
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

Review 4.  Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.

Authors:  Hanhee Cho; Seong Ik Jeon; Cheol-Hee Ahn; Man Kyu Shim; Kwangmeyung Kim
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

5.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

6.  Hepatic uptake of a modified low molecular weight heparin in rats.

Authors:  G Stehle; E A Friedrich; H Sinn; A Wunder; J Harenberg; C E Dempfle; W Maier-Borst; D L Heene
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

7.  Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles.

Authors:  E A Wallnöfer; G C Thurner; C Kremser; H Talasz; M M Stollenwerk; A Helbok; N Klammsteiner; K Albrecht-Schgoer; H Dietrich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2020-10-11       Impact factor: 4.304

8.  Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes.

Authors:  Björn Gustafsson; Ulf Hedin; Kenneth Caidahl
Journal:  Contrast Media Mol Imaging       Date:  2014-04-22       Impact factor: 3.161

Review 9.  Albumin-based drug delivery: harnessing nature to cure disease.

Authors:  Maja Thim Larsen; Matthias Kuhlmann; Michael Lykke Hvam; Kenneth A Howard
Journal:  Mol Cell Ther       Date:  2016-02-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.